Exane Derivatives’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5
| Closed | -$861 | – | 780 |
|
|
2022
Q1 | $861 | Hold |
5
| – | – | ﹤0.01% | 810 |
|
|
2021
Q4 | $809 | Sell |
5
-259
| -98% | -$41.9K | ﹤0.01% | 716 |
|
|
2021
Q3 | $39.4K | Sell |
264
-3,361
| -93% | -$501K | 0.01% | 630 |
|
|
2021
Q2 | $958K | Buy |
+3,625
| New | +$958K | 0.22% | 94 |
|
|
2021
Q1 | – | Sell |
-903
| Closed | -$265K | – | 882 |
|
|
2020
Q4 | $265K | Buy |
903
+539
| +148% | +$158K | 0.08% | 259 |
|
|
2020
Q3 | $86.1K | Buy |
+364
| New | +$86.1K | 0.02% | 310 |
|